ReviewJournal of oncology2022

Safety and Efficacy of Treatment with/without Ramucirumab in Advanced or Metastatic Cancer: A Meta-Analysis of 11 Global, Double-Blind, Phase 3 Randomized Controlled Trials.

Lingxue Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.